መነሻ › በርኪት ሊምፎማ › Pennsylvania

በPennsylvania ለበርኪት ሊምፎማ የሚደረጉ ክሊኒካዊ ጥናቶች

ለበርኪት ሊምፎማ የሚደረጉ 18 ጥናቶች በPennsylvania ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።

በPennsylvania ውስጥ ያሉ ከተሞች

Official study text (English)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Lehigh Valley Hospital-Cedar Crest, Allentown
Penn State Children's Hospital, Hershey
Children's Hospital of Philadelphia, Philadelphia
እና 2 ተጨማሪ

ተሳታዮችን በመፈለግ ላይደረጃ 2

366 Days – 46 Years · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT06124157

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

Lehigh Valley Hospital-Cedar Crest, Allentown
Lehigh Valley Hospital - Muhlenberg, Bethlehem
University of Pennsylvania/Abramson Cancer Center, Philadelphia
እና 1 ተጨማሪ

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ ከ18 እስከ 39 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT03150693

Blinatumomab Consolidation in Real World

University of Pennsylvania, Philadelphia

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT07117136

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Children's Hospital of Philadelphia, Philadelphia

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት

እድሜ ከ0 እስከ 38 · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT06131801

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Lehigh Valley Hospital-Cedar Crest, Allentown
Geisinger Medical Center, Danville
Penn State Children's Hospital, Hershey
እና 2 ተጨማሪ

ተሳታዮችን በመፈለግ ላይደረጃ 2

365 Days · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06317662

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

Penn State Hershey Medical Center, Hershey

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ21 ሴፕቴ 2026 · NCT07648264

A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia

Children's Hospital of Philadelphia (Data Collection Only), Philadelphia

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ 1 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ሴፕቴ 2026 · NCT07223021

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Children's Hospital of Philadelphia (CHOP) ( Site 1021), Philadelphia

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

6 Months – 25 Years · ሁሉም ጾታዎች · የተሻሻለው በ17 ሴፕቴ 2026 · NCT06395103

A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)

Children's Hospital of Philadelphia, Philadelphia

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ ከ0 እስከ 18 · ሁሉም ጾታዎች · የተሻሻለው በ16 ሴፕቴ 2026 · NCT06173518

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Lehigh Valley Hospital-Cedar Crest, Allentown
Geisinger Medical Center, Danville
Penn State Children's Hospital, Hershey
እና 3 ተጨማሪ

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ ከ1 እስከ 30 · ሁሉም ጾታዎች · የተሻሻለው በ1 ሴፕቴ 2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Lehigh Valley Hospital-Cedar Crest, Allentown
Geisinger Medical Center, Danville
Penn State Children's Hospital, Hershey
እና 3 ተጨማሪ

ተሳታዮችን በመፈለግ ላይደረጃ 3

365 Days – 25 Years · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT03959085

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Children's Hospital of Philadelphia, Philadelphia

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ ከ7 እስከ 25 · ሁሉም ጾታዎች · የተሻሻለው በ19 ኦገስ 2026 · NCT05082519

Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With Specific Changes in the MYC Gene

UPMC Hillman Cancer Center, Pittsburgh

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ31 ጁላይ 2026 · NCT07069699

CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT

Children's Hospital of Philadelphia, Philadelphia

ተሳታዮችን በመፈለግ ላይ

እስከ እድሜ 25 · ሁሉም ጾታዎች · የተሻሻለው በ8 ጁላይ 2026 · NCT03810196

Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)

Children's Hospital of Philadelphia, Philadelphia

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ ከ0 እስከ 29 · ሁሉም ጾታዎች · የተሻሻለው በ26 ሜይ 2026 · NCT05480449

Co-administration of CART22-65s and huCART19 for B-ALL

Children's Hospital of Philadelphia, Philadelphia

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እስከ እድሜ 29 · ሁሉም ጾታዎች · የተሻሻለው በ27 ማርች 2026 · NCT05674175

Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)

Children's Hospital of Philadelphia, Philadelphia

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ ከ15 እስከ 50 · ሁሉም ጾታዎች · የተሻሻለው በ9 ሴፕቴ 2025 · NCT04150497

Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia

AHN Cancer Institute - West Penn Hospital, Pittsburgh

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ ከ18 እስከ 79 · ሁሉም ጾታዎች · የተሻሻለው በ13 ጃንዩ 2025 · NCT05281809

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።